Siemens to Replace Healthineers CFO in Preparation for Listing Post author:Sam Post published:November 8, 2017 Post category:BioPharma The public listing that is expected to value the business at around $46 billion. Source: BioSpace You Might Also Like Novo Nordisk’s Positive Phase III Data for Oral Diabetic Drug Heats Up the Competition February 21, 2018 Seegene Enters The U.S. Diagnostic Market In Collaboration With Thermo Fisher Scientific May 22, 2017 SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs January 30, 2018
Novo Nordisk’s Positive Phase III Data for Oral Diabetic Drug Heats Up the Competition February 21, 2018
Seegene Enters The U.S. Diagnostic Market In Collaboration With Thermo Fisher Scientific May 22, 2017
SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs January 30, 2018
